Here's Eli Lilly's Competitive Advantage in GLP-1 Obesity Drugs and Abbott's Supporting Role
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Test tubes are seen in front of an AbbVie logo in this illustration taken on May 21, 2021. Ruvic Dice…
2023 was not a good year for the healthcare sector, but some investors expect it to return this year, highlighting…